XM không cung cấp dịch vụ cho cư dân của Mỹ.
B
B

Baloise


Tin tức

Vontobel assesses obesity drugs impact for Swiss insurers, med-tech companies

BUZZ-Vontobel assesses obesity drugs impact for Swiss insurers, med-tech companies ** Vontobel estimates the market potential for obesity drugs in the U.S. to reach a three-digit billion U.S. dollar amount and picks Swiss Re SRENH.S and Ypsomed YPSN.S as the most likely to profit from it ** Among Swiss life insurers, Swiss Re could benefit the most from a rising demand in life and health reinsurance, with a market share of about 15%, as obesity drugs improve life expectancy, it says ** Its posit
B
H
N
R
S
S
Z

MTU Aero Engines, Nestle, Vusiongroup

EUROPE RESEARCH ROUNDUP- MTU Aero Engines, Nestle, Vusiongroup Sept 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including MTU Aero Engines, Nestle and Vusiongroup, on Monday. HIGHLIGHTS * Advanced Medical Solutions Group Plc AMSU.L : Peel Hunt raises target to 246p from 220p * MTU Aero Engines AG MTXGn.DE : Citigroup cuts to sell from neutral * Nestle SA NESN.S : Morgan Stanley cuts to underweight from equal-weight * Sodexo EXHO.PA : B
A
A
B
B
C
D
I
I
M
M
N
N
S
A
A
P

Swiss stocks - Factors to watch on September 16

Swiss stocks - Factors to watch on September 16 ZURICH/GDANSK, Sept 16(Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday: SOFTWAREONE HOLDING SWON.S Swiss technology firm was exploring a potential merger with smaller Norwegian competitor Crayon Group Holding CRAYN.OL , Bloomberg News reported on Friday, citing people familiar with the matter.
B

Baloise's new strategy not bold enough, say investors

Baloise's new strategy not bold enough, say investors By Oliver Hirt ZURICH, Sept 13 (Reuters) - Investors in Baloise BALN.S say the Swiss insurer's plans to shake up its business with bigger returns to shareholders and job cuts are unlikely to be enough to satisfy the market, and it may end up having to sell parts of its business. Baloise unveiled its strategy on Thursday and said it could also consider share buybacks next year.
B

Activist investor Cevian unimpressed by Baloise proposals

Activist investor Cevian unimpressed by Baloise proposals ZURICH, Sept 12 (Reuters) - Activist investor Cevian on Thursday said it was unimpressed by Baloise's proposals BALN.S to improve performance at the Swiss insurer. "For Baloise to become a great Swiss insurance company, real focus and real ambition are needed," said Cevian partner Robert Schuchna.
B

Baloise eyeing changes in board of directors, chairman says

UPDATE 1-Baloise eyeing changes in board of directors, chairman says Adds details throughout By Oliver Hirt ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S is considering changes in its board of directors, Chairman Thomas von Planta said on Thursday after the company revealed plans to boost returns to shareholders. "We want to strengthen the insurance expertise on the board," von Planta told Reuters in an interview.
B

Baloise eyeing changes in board of directors, chairman says

Baloise eyeing changes in board of directors, chairman says ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S is considering changes in its board of directors, Chairman Thomas von Planta said on Thursday after the company revealed plans to boost returns to shareholders. "We want to strengthen the insurance expertise on the board," von Planta told Reuters in an interview.
B

Swiss insurer Baloise targets higher shareholder returns after Cevian move

UPDATE 5-Swiss insurer Baloise targets higher shareholder returns after Cevian move Baloise to boost return on equity, cut jobs, considers buybacks CEO emphasizes efficiency and core business performance Chairman says board changes under consideration Adds comment from Cevian, paragraphs 2, 6-7 By Oliver Hirt ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S said on Thursday it plans to boost return on equity, cut jobs and will consider share buybacks after Swedish activist investor Cevia
B

Baloise targets higher returns for shareholders after Cevian move

Baloise targets higher returns for shareholders after Cevian move ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S said on Thursday it plans to boost return on equity and will consider share buybacks after activist investor Cevian Capital this week revealed it held over 9% of the company's stock, becoming its top stakeholder. Baloise said in a statement that its new targets include a return on equity of 12% to 15%, cash remittance of more than 2 billion Swiss francs ($2.34 billion) in th
B

Baloise Volume Of Business Stood At CHF 5.29 Bln

BRIEF-Baloise Volume Of Business Stood At CHF 5.29 Bln Sept 12 (Reuters) - BALOISE HOLDING AG BALN.S : BALOISE GENERATES GROWTH IN ITS ATTRACTIVE NON-LIFE BUSINESS AND REPORTS AN ENCOURAGING PROFIT DESPITE HIGHER CLAIMS INCURRED VOLUME OF BUSINESS STOOD AT CHF 5,293.0 MILLION (H1 2023: CHF 5,339.9 MILLION) PROFIT ATTRIBUTABLE TO SHAREHOLDERS FOR FI
B

Baloise Launches Its Refocusing Strategy

BRIEF-Baloise Launches Its Refocusing Strategy Sept 12 (Reuters) - BALOISE HOLDING AG BALN.S : BALOISE LAUNCHES ITS REFOCUSING STRATEGY, RAISES PAYOUT RATE AND AIMS FOR A RETURN ON EQUITY OF BETWEEN 12 PER CENT AND 15 PER CENT ANNOUNCING START OF A REFOCUSING STRATEGY THAT INCLUDES MEASURES RELATED TO TECHNICAL PROFITABILITY, OPERATIONAL EFFICIENCY
B

Swiss stocks - Factors to watch on September 12

Swiss stocks - Factors to watch on September 12 ZURICH/GDANSK, Sep 12(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: Roche ROG.S Roche said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July were based on just six patients, underscoring the uncertainty of the development project.
B
R
S

Investors press Baloise to shake up business after Cevian swoop

Investors press Baloise to shake up business after Cevian swoop By Oliver Hirt and Paul Arnold ZURICH, Sept 10 (Reuters) - Swiss insurer Baloise BALN.S is under pressure to heed shareholder demands to shake up its portfolio and boost returns since activist investor Cevian Capital said it held over 9% of the company's stock, becoming its biggest stakeholder.
A
B
H
A
A
S
Z

Europe set to bounce back

LIVE MARKETS-Europe set to bounce back Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EUROPE SET TO BOUNCE BACK European shares were set to rise at the open on Monday as gains in Wall Street futures pointed to a stabilisation in markets following last week's widespread losses on concerns over a cooling U.S.
B
K
U
E
F
U
G

Activist investor Cevian ups stake in Baloise to 9.4%

UPDATE 1-Activist investor Cevian ups stake in Baloise to 9.4% Adds comment from Baloise, further details ZURICH, Sept 9 (Reuters) - Activist investor Cevian Capital has increased its stake in Baloise Holding BALN.S , it said on Monday, increasing its ability to force changes at the Swiss insurer. Cevian now holds around 9.4% in Baloise, the biggest investor in the company.
A
B
U

Swiss stocks - Factors to watch on September 9

Swiss stocks - Factors to watch on September 9 Sept 9 - Here are some of the main factors that may affect Swiss stocks on Monday: BALOISE HOLDING AG BALN.S Activist investor Cevian Capital has increased its stake in Baloise Holding BALN.S, it said on Monday, increasing its ability to force changes at the Swiss insurer. ECONOMY SNB data on Swiss sight deposits due at 0800 GMT.
B

Activist investor Cevian ups stake in Baloise to 9.4%

Activist investor Cevian ups stake in Baloise to 9.4% ZURICH, Sept 9 (Reuters) - Activist investor Cevian Capital has increased its stake in Baloise Holding BALN.S , it said on Monday, increasing its ability to force changes at the Swiss insurer. Cevian now holds a position of around 9.4% in Baloise, becoming the biggest investor in the company. The investment is an increase from the 3.12% stake held by Cevian in Baloise revealed earlier this year .
A
B
U

Activist Cevian presses Swiss insurer Baloise for strategy reset, FT reports

UPDATE 1-Activist Cevian presses Swiss insurer Baloise for strategy reset, FT reports Updates with details paragraph 2 onwards Sept 9 (Reuters) - Activist investor Cevian is pressing for a strategic overhaul at Swiss insurance group Baloise BALN.S after building up a stake of more than 9% in the company, the Financial Times reported on Monday. The activist investor wants the management of the Swiss insurer to refocus on countries where it is strongest and has a high market share, and direct more
A
B
U

Australia's Westpac names new CEO, moving on from governance crisis

UPDATE 4-Australia's Westpac names new CEO, moving on from governance crisis Writes through with fresh current and former CEO quotes, updated shares By Byron Kaye and Adwitiya Srivastava Sept 9 (Reuters) - Westpac WBC.AX , Australia's second-largest mortgage lender by loans, promoted the head of its business and wealth unit to CEO, vowing to capitalise on improved governance while growing its business lending book.
A
B
D
G
N
U
W

Europe's STOXX 600 corporate earnings week ahead

DIARY-Europe's STOXX 600 corporate earnings week ahead Sept 6 (Reuters) - Diary of Europe's STOXX 600 (.STOXX) corporate earnings for the week ahead EUROPE'S STOXX 600 EARNINGS Start Date Start Time(GMT) RIC Company Name Event Name 09-Sep-2024 20:00 ASML.AS ASML Holding NV ASML Holding NV Meet the Management: Lung Cancer and QCS Presentation 09-Sep-2024 NTS IETB.BR D'Ieteren Group SA Half Year 2024 D'Ieteren Group NV Earnings Release 09-Sep-2024 12:15 SRENH.S Swiss Re AG Swiss Re AG Media Confer
B
C
D
I
R
A
S



Các điều kiện

Các tài sản phổ thông

Khước từ trách nhiệm: các tổ chức thuộc XM Group chỉ cung cấp dịch vụ khớp lệnh và truy cập Trang Giao dịch trực tuyến của chúng tôi, cho phép xem và/hoặc sử dụng nội dung có trên trang này hoặc thông qua trang này, mà hoàn toàn không có mục đích thay đổi hoặc mở rộng. Việc truy cập và sử dụng như trên luôn phụ thuộc vào: (i) Các Điều kiện và Điều khoản; (ii) Các Thông báo Rủi ro; và (iii) Khước từ trách nhiệm toàn bộ. Các nội dung như vậy sẽ chỉ được cung cấp dưới dạng thông tin chung. Đặc biệt, xin lưu ý rằng các thông tin trên Trang Giao dịch trực tuyến của chúng tôi không phải là sự xúi giục, mời chào để tham gia bất cứ giao dịch nào trên các thị trường tài chính. Giao dịch các thị trường tài chính có rủi ro cao đối với vốn đầu tư của bạn.

Tất cả các tài liệu trên Trang Giao dịch trực tuyến của chúng tôi chỉ nhằm các mục đích đào tạo/cung cấp thông tin và không bao gồm - và không được coi là bao gồm - các tư vấn tài chính, đầu tư, thuế, hoặc giao dịch, hoặc là một dữ liệu về giá giao dịch của chúng tôi, hoặc là một lời chào mời, hoặc là một sự xúi giục giao dịch các sản phẩm tài chính hoặc các chương trình khuyến mãi tài chính không tự nguyện.

Tất cả nội dung của bên thứ ba, cũng như nội dung của XM như các ý kiến, tin tức, nghiên cứu, phân tích, giá cả, các thông tin khác hoặc các đường dẫn đến trang web của các bên thứ ba có trên trang web này được cung cấp với dạng "nguyên trạng", là các bình luận chung về thị trường và không phải là các tư vấn đầu tư. Với việc các nội dung đều được xây dựng với mục đích nghiên cứu đầu tư, bạn cần lưu ý và hiểu rằng các nội dung này không nhằm mục đích và không được biên soạn để tuân thủ các yêu cầu pháp lý đối với việc quảng bá nghiên cứu đầu tư này và vì vậy, được coi như là một tài liệu tiếp thị. Hãy chắc chắn rằng bạn đã đọc và hiểu Thông báo về Nghiên cứu Đầu tư không độc lập và Cảnh báo Rủi ro tại đây liên quan đến các thông tin ở trên.

Cảnh báo rủi ro: Vốn của bạn bị rủi ro. Các sản phẩm có đòn bẩy có thể không phù hợp với tất cả mọi người. Hãy xem kỹ Thông báo rủi ro của chúng tôi.